Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss

11 Mar 2023

Abstract excerpt

// Maroun Bou Zerdan 1 , Prashanth Ashok Kumar 2 , Elio Haroun 3 , Nimisha Srivastava 2 , Jeffrey Ross 4 , 5 and Abirami Sivapiragasam 2 1 Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA 2 Department of Internal Medicine, Division of Hematology Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA 3 SUNY Upstate Medical University, Syracuse, NY 13210, USA 4...

Topics

Join the communities discussing this publication.

Epigenetics and DNA Methylation
RNA modifications and cancer
Viral-associated cancers and disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36913304
DOI: 10.18632/oncotarget.28376

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) lossPMID 36913304Read ↗

Prevalence and molecular features of TMB-high and MSI-high breast cancer assessed by gene panel testingSemantic proximity Read ↗

Genomic Alteration in Metastatic Breast Cancer and Its TreatmentSemantic proximity Read ↗

Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors.Semantic proximity Read ↗

Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal CancersSemantic proximity Read ↗

Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.Semantic proximity Read ↗

Real-World Landscape of Genomic Medicine in Breast Cancer Revealed by the C-CAT Database: Reappraisal of Drug Accessibility and Clinical Utility in 6,307 PatientsSemantic proximity Read ↗

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.Semantic proximity Read ↗

Molecular characterization of metaplastic breast carcinoma via next-generation sequencingSemantic proximity Read ↗

Genomic landscape of metastatic breast cancers in young adults: a liquid biopsy analysis of women aged 20-40 years.Semantic proximity Read ↗

Prevalence and mutational determinants of high tumor mutation burden in breast cancerSemantic proximity Read ↗

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequenciesSemantic proximity Read ↗

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.